-

Humana Inc. to Present at Upcoming Industry Conferences

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top on Thursday, January 6, 2022 at 1:00 p.m. Eastern time.

Senior management is also scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at 3:45 p.m. Eastern time.

A live audio webcast of the presentations will be available via Humana’s Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of each presentation to allow time to run a system test and download any free software needed for access purposes.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases
  • Calendar of events
  • Corporate Governance information

 

Contacts

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: mtaylor108@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: mtaylor108@humana.com

More News From Humana Inc.

Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 1Q26 (a) 1Q25 (a) Generally Accepted Accounting Principles (GAAP) $1,595   $1,691 Amortization associated with identifiable intangibles 11   15 Pu...

Humana Board Declares Payment of Quarterly Dividend to Stockholders

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – de...

Humana Elects Robert S. Field to Board of Directors

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company’s Board of Directors, effective immediately following the Company’s 2026 Annual Meeting of Stockholders. Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry. He previously served as a senior analyst at Luxor Capital, a multi-strateg...
Back to Newsroom